Sesamol-Loaded PLGA Nanosuspension for Accelerating Wound Healing in Diabetic Foot Ulcer in Rats

Karthik Gourishetti,1 Raghuvir Keni,1 Pawan Ganesh Nayak,1 Srinivas Reddy Jitta,2 Navya Ajitkumar Bhaskaran,2 Lalit Kumar,2 Nitesh Kumar,1 Nandakumar Krishnadas,1 Rekha Raghuveer Shenoy1 1Department of Pharmacology, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Man...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Gourishetti K, Keni R, Nayak PG, Jitta SR, Bhaskaran NA, Kumar L, Kumar N, Krishnadas N, Shenoy RR
Formato: article
Lenguaje:EN
Publicado: Dove Medical Press 2020
Materias:
Acceso en línea:https://doaj.org/article/f5930e8cfee74b62b84dc7f42067cbd4
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:f5930e8cfee74b62b84dc7f42067cbd4
record_format dspace
spelling oai:doaj.org-article:f5930e8cfee74b62b84dc7f42067cbd42021-12-02T14:59:19ZSesamol-Loaded PLGA Nanosuspension for Accelerating Wound Healing in Diabetic Foot Ulcer in Rats1178-2013https://doaj.org/article/f5930e8cfee74b62b84dc7f42067cbd42020-11-01T00:00:00Zhttps://www.dovepress.com/sesamol-loaded-plga-nanosuspension-for-accelerating-wound-healing-in-d-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Karthik Gourishetti,1 Raghuvir Keni,1 Pawan Ganesh Nayak,1 Srinivas Reddy Jitta,2 Navya Ajitkumar Bhaskaran,2 Lalit Kumar,2 Nitesh Kumar,1 Nandakumar Krishnadas,1 Rekha Raghuveer Shenoy1 1Department of Pharmacology, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal 576104, Karnataka, India; 2Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal 576104, Karnataka, IndiaCorrespondence: Rekha Raghuveer ShenoyDepartment of Pharmacology, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal 576104, Karnataka, IndiaTel +91-820-2922482Fax +91-820-2571998Email rekhaarunt@gmail.comBackground: Diabetic foot ulcer is an intractable complication of diabetes, characterized by the disturbed inflammatory and proliferative phases of wound healing. Sesamol, a phenolic compound, has been known for its powerful antioxidant, anti-inflammatory, anti-hyperglycaemic and wound healing properties. The aim of the present study was to develop a sesamol nano formulation and to study its effect on the various phases of the wound healing process in diabetic foot condition.Methods: Sesamol-PLGA (SM-PLGA) nanosuspension was developed  using nanoprecipitation method. TEM, in vitro drug release assay and in vivo pharmacokinetic studies were performed for the optimised formulation. Diabetic foot ulcer (DFU) in high fat diet (HFD)-fed streptozotocin-induced type-II diabetic animal model was used to assess the SM-PLGA nanosuspension efficacy. SM-PLGA nanosuspension was administered by oral route. TNF-α levels were estimated using ELISA and Western blot analysis was performed to assess the effect on the expression of HSP-27, ERK, PDGF-B and VEGF in wound tissue. Wound re-epithelization, fibroblast migration, collagen deposition and inflammatory cell infiltration were assessed by H&E and Masson’s trichrome staining. Effect on angiogenesis was assessed by CD-31 IHC staining in wound sections.Results: The optimized SM-PLGA nanosuspension had an average particle size of < 300 nm, PDI< 0.200 with spherical shaped particles. Approximately 80% of the drug was released over a period of 60 h in in vitro assay. Half-life of the formulation was found to be 13.947 ± 0.596 h. SM-PLGA nanosuspension treatment decreased TNF-α levels in wound tissue and accelerated the collagen deposition. Whereas, HSP-27, ERK, PDGF-B and VEGF expression increased and improved new blood vessels’ development. Rapid re-epithelization, fibroblast migration, collagen deposition and reduced inflammatory cell infiltration at the wound site were also observed.Conclusion: Results indicate that sesamol-PLGA nanosuspension significantly promotes the acceleration of wound healing in diabetic foot ulcers by restoring the altered wound healing process in diabetic condition.Keywords: diabetes, diabetic foot ulcer, sesamol, PLGA, nanosuspension, controlled release, wound healing, re-epithelization, angiogenesis, TNF-αGourishetti KKeni RNayak PGJitta SRBhaskaran NAKumar LKumar NKrishnadas NShenoy RRDove Medical Pressarticlediabetesdiabetic foot ulcersesamolplgananosuspensioncontrolled releasewound healingre-epithelizationangiogenesistnf-αMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 15, Pp 9265-9282 (2020)
institution DOAJ
collection DOAJ
language EN
topic diabetes
diabetic foot ulcer
sesamol
plga
nanosuspension
controlled release
wound healing
re-epithelization
angiogenesis
tnf-α
Medicine (General)
R5-920
spellingShingle diabetes
diabetic foot ulcer
sesamol
plga
nanosuspension
controlled release
wound healing
re-epithelization
angiogenesis
tnf-α
Medicine (General)
R5-920
Gourishetti K
Keni R
Nayak PG
Jitta SR
Bhaskaran NA
Kumar L
Kumar N
Krishnadas N
Shenoy RR
Sesamol-Loaded PLGA Nanosuspension for Accelerating Wound Healing in Diabetic Foot Ulcer in Rats
description Karthik Gourishetti,1 Raghuvir Keni,1 Pawan Ganesh Nayak,1 Srinivas Reddy Jitta,2 Navya Ajitkumar Bhaskaran,2 Lalit Kumar,2 Nitesh Kumar,1 Nandakumar Krishnadas,1 Rekha Raghuveer Shenoy1 1Department of Pharmacology, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal 576104, Karnataka, India; 2Department of Pharmaceutics, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal 576104, Karnataka, IndiaCorrespondence: Rekha Raghuveer ShenoyDepartment of Pharmacology, Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Manipal 576104, Karnataka, IndiaTel +91-820-2922482Fax +91-820-2571998Email rekhaarunt@gmail.comBackground: Diabetic foot ulcer is an intractable complication of diabetes, characterized by the disturbed inflammatory and proliferative phases of wound healing. Sesamol, a phenolic compound, has been known for its powerful antioxidant, anti-inflammatory, anti-hyperglycaemic and wound healing properties. The aim of the present study was to develop a sesamol nano formulation and to study its effect on the various phases of the wound healing process in diabetic foot condition.Methods: Sesamol-PLGA (SM-PLGA) nanosuspension was developed  using nanoprecipitation method. TEM, in vitro drug release assay and in vivo pharmacokinetic studies were performed for the optimised formulation. Diabetic foot ulcer (DFU) in high fat diet (HFD)-fed streptozotocin-induced type-II diabetic animal model was used to assess the SM-PLGA nanosuspension efficacy. SM-PLGA nanosuspension was administered by oral route. TNF-α levels were estimated using ELISA and Western blot analysis was performed to assess the effect on the expression of HSP-27, ERK, PDGF-B and VEGF in wound tissue. Wound re-epithelization, fibroblast migration, collagen deposition and inflammatory cell infiltration were assessed by H&E and Masson’s trichrome staining. Effect on angiogenesis was assessed by CD-31 IHC staining in wound sections.Results: The optimized SM-PLGA nanosuspension had an average particle size of < 300 nm, PDI< 0.200 with spherical shaped particles. Approximately 80% of the drug was released over a period of 60 h in in vitro assay. Half-life of the formulation was found to be 13.947 ± 0.596 h. SM-PLGA nanosuspension treatment decreased TNF-α levels in wound tissue and accelerated the collagen deposition. Whereas, HSP-27, ERK, PDGF-B and VEGF expression increased and improved new blood vessels’ development. Rapid re-epithelization, fibroblast migration, collagen deposition and reduced inflammatory cell infiltration at the wound site were also observed.Conclusion: Results indicate that sesamol-PLGA nanosuspension significantly promotes the acceleration of wound healing in diabetic foot ulcers by restoring the altered wound healing process in diabetic condition.Keywords: diabetes, diabetic foot ulcer, sesamol, PLGA, nanosuspension, controlled release, wound healing, re-epithelization, angiogenesis, TNF-α
format article
author Gourishetti K
Keni R
Nayak PG
Jitta SR
Bhaskaran NA
Kumar L
Kumar N
Krishnadas N
Shenoy RR
author_facet Gourishetti K
Keni R
Nayak PG
Jitta SR
Bhaskaran NA
Kumar L
Kumar N
Krishnadas N
Shenoy RR
author_sort Gourishetti K
title Sesamol-Loaded PLGA Nanosuspension for Accelerating Wound Healing in Diabetic Foot Ulcer in Rats
title_short Sesamol-Loaded PLGA Nanosuspension for Accelerating Wound Healing in Diabetic Foot Ulcer in Rats
title_full Sesamol-Loaded PLGA Nanosuspension for Accelerating Wound Healing in Diabetic Foot Ulcer in Rats
title_fullStr Sesamol-Loaded PLGA Nanosuspension for Accelerating Wound Healing in Diabetic Foot Ulcer in Rats
title_full_unstemmed Sesamol-Loaded PLGA Nanosuspension for Accelerating Wound Healing in Diabetic Foot Ulcer in Rats
title_sort sesamol-loaded plga nanosuspension for accelerating wound healing in diabetic foot ulcer in rats
publisher Dove Medical Press
publishDate 2020
url https://doaj.org/article/f5930e8cfee74b62b84dc7f42067cbd4
work_keys_str_mv AT gourishettik sesamolloadedplgananosuspensionforacceleratingwoundhealingindiabeticfootulcerinrats
AT kenir sesamolloadedplgananosuspensionforacceleratingwoundhealingindiabeticfootulcerinrats
AT nayakpg sesamolloadedplgananosuspensionforacceleratingwoundhealingindiabeticfootulcerinrats
AT jittasr sesamolloadedplgananosuspensionforacceleratingwoundhealingindiabeticfootulcerinrats
AT bhaskaranna sesamolloadedplgananosuspensionforacceleratingwoundhealingindiabeticfootulcerinrats
AT kumarl sesamolloadedplgananosuspensionforacceleratingwoundhealingindiabeticfootulcerinrats
AT kumarn sesamolloadedplgananosuspensionforacceleratingwoundhealingindiabeticfootulcerinrats
AT krishnadasn sesamolloadedplgananosuspensionforacceleratingwoundhealingindiabeticfootulcerinrats
AT shenoyrr sesamolloadedplgananosuspensionforacceleratingwoundhealingindiabeticfootulcerinrats
_version_ 1718389238724034560